Physician profile
Basem Hakim
NPI 1700440351
$1,191.59
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $239 · 2023: $207 · 2024: $628 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578 · Travel and Lodging: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.86 |
| Travel and Lodging | $374.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Voom Medical Devices, INC. | $374.93 | 2024 | Revcon |
| Smith+Nephew, INC. | $231.41 | 2022-2024 | Grafix Pl, Collagenase Santyl |
| Stryker Corporation | $162.83 | 2022 | |
| Orthofix Medical, INC. | $141.89 | 2024 | Physio-Stim |
| Polynovo North America LLC | $70.03 | 2024 | Novosorb Btm |
| Paratek Pharmaceuticals, INC. | $66.42 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $46.08 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sebela Pharmaceuticals INC. | $31.81 | 2022 | |
| Tactile Systems Technology INC | $23.98 | 2025 | Flexitouch Plus, Nimbl |
| Bioventus LLC | $21.74 | 2025 | Exogen Ultrasound Bone Healing System |
| Musculoskeletal Transplant Foundation INC. | $20.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basem Hakim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.